Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Laws and Regulations

Type Signature Number Date Topic Document
Circular Minister of Public Health
 
9 9-3-2022 Related to providing specialized mental health medications in primary health care centers
 
Circular Number 9: Related to providing specialized mental health medications in primary health care centers
 
Decision Minister of Public Health 271/1 25/02/2019 Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision Minister of Public Health 270/1 25/02/2019 Related to the Quality of Care and Human Rights in the Field of Mental Health  Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health

Circular 

Director General

60

20/06/2018

Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system

Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system

Circular  Director General 112 27/11/2018 Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular  Director General 113 22/11/2018 Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational) Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision Minister of Public Health 1155 19-06-2018 Decision related to the National Mental Health Programme Decision number 1155: related to the National Mental Health Programme
Circular Director General 22 09-03-2018 Regulation of studies and research in the field of mental health and psychosocial support Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe   1320/1 02-2018 Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession. Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular Director General 48 12-06-2017 Regulation of research in the field of mental health Circular number 48: Related to the regulation of research in the field of mental health
Circular Director General 64 12-06-2017 Projects related to MHPSS and substance use in Lebanon Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular Director General 46 22-03-2016 Request to hospitals to not report on overdose Circular number 46: related to the request to hospitals to not report on overdose
Circular
 
Director General
 
66
 
20-6-2025
 
Regarding Specialized Mental Health Medications
 
Circular number 66: Concerning Specialized Mental Health Medications
 
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
A03FA09 MOSAR B Mosapride citrate - 5mg 5mg Tablet, coated 798,242 L.L
J02AX05 MYCAMINE B Micafungin (sodium) - 50mg 50mg Injectable lyophilised powder for solution 13,170,341 L.L
H05BA01 MIACALCIC B Calcitonin (salmon synthetic) - 100IU/ml 100IU/ml Injectable solution 1,720,118 L.L
J01DH02 MERONEM B Meropenem (trihydrate) - 500mg 500mg Injectable powder for solution 10,398,061 L.L
H05BA01 MIACALCIC 200 UI/ACTUATION B Calcitonin (salmon synthetic) - 200IU/actuation 200IU/actuation Solution 5,399,559 L.L
J01DH02 MERONEM B Meropenem (trihydrate) - 1g 1g Injectable powder for solution 10,398,061 L.L
S01EB02 MIOSTAT STERIL INTRAOCULAR B Carbachol - 0.01% 0.01% Solution 8,117,591 L.L
L01BB04 MAVENCLAD B Cladribine - 10mg 10mg Tablet L.L
M03BX04 MYDOCALM B Tolperisone - 150mg 150mg Tablet, film coated 839,902 L.L
G03GA02 MENO-CLAIR HP-HMG BioHuman Human Menopausal Gonadotrophin, Highly purified - 75IU 75IU Injectable powder for solution + solution 1,045,509 L.L
G03GA02 MENOPUR BioHuman Menotropin - 75IU 75IU Injectable concentrated powder for solution+diluent 16,864,077 L.L
G03GA02 MERIONAL HG BioHuman Menotropin - 75IU 75IU Injectable powder + solvent 16,423,597 L.L
G03GA02 MENOPUR BioHuman Menotropin - 1,200IU 1,200IU Injectable powder for solution+diluent 27,815,659 L.L
G03GA02 MENOPUR BioHuman Menotropin - 600IU 600IU Injectable powder for solution+diluent 13,907,829 L.L
G03GA02 MENO-CLAIR HP-HMG BioHuman Human Menopausal Gonadotrophin, Highly purified - 150IU 150IU Injectable powder for solution + solution 2,005,013 L.L
G03GA02 MERIONAL HG BioHuman Menotropin - 150IU 150IU Injectable powder + solvent 41,777,992 L.L
G03GA02 MERIONAL HG BioHuman Menotropin - 900IU 900IU Injectable powder + solvent 25,830,983 L.L
L01FX02 MYLOTARG BioTech Gemtuzumab Ozogamicin - 4.5mg 4.5mg Injectable powder L.L
L01EE03 MEKTOVI BioTech Binimetinib - 15mg 15mg Tablet, film coated 257,694,409 L.L
A10AD01 MIXTARD 30 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 752,552 L.L
A10AD01 MIXTARD 30 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 752,552 L.L
L01FA01 MABIXEN 100 BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 22,183,393 L.L
L01FA01 MABIXEN 100 BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 11,091,696 L.L
L01FA01 MABTHERA BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrated solution 35,722,424 L.L
L01FA01 MABIXEN 500 BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 136,761,210 L.L
L01FA01 MABIXEN 500 BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 74,718,320 L.L
L01FA01 MABTHERA BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrated solution 80,211,932 L.L
A16AB07 MYOZYME BioTech Alglucosidase alfa, recombinant human acid - 50mg 50mg Injectable powder for concentrate for solution 56,536,307 L.L
L01FD01 MABTIN 440 BioTech Trastuzumab (r-DNA origin) - 440mg 440mg Injectable powder for solution 70,042,700 L.L
A16AB07 MYOZYME BioTech Alglucosidase alfa, recombinant human acid - 50mg 50mg Injectable powder for concentrate for solution L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025